Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular events
Top Cited Papers
Open Access
- 30 July 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 13 (8), 1109-1114
- https://doi.org/10.1002/lt.21126
Abstract
Cardiac and cerebral vascular diseases are leading causes of morbidity and death in solid organ transplant recipients. Immunosuppressant drugs are associated with dyslipidemia, hypertension, and hyperglycemia, which along with obesity are the main features of metabolic syndrome. In the nontransplant population, metabolic syndrome is associated with increased risk for major vascular complications. We postulated that metabolic syndrome is common post–liver transplantation and plays a significant role leading to cardiac and cerebrovascular events. Our Multi-Organ Transplant Program database was reviewed for all liver transplant recipients between January 1998 and June 2004 with follow-up until December 2005. We adapted the 2001 National Cholesterol Education Program-Adult Treatment Panel III Guidelines to define posttransplantation metabolic syndrome (PTMS) as the presence at least 3 of the following: 1) obesity (body mass index >30 kg/m2); 2) serum triglyceride level ≥1.7 mmol/L; 3) high density lipoprotein level P = 0.003) during the study period. In conclusion, the prevalence of metabolic syndrome post–liver transplant is significantly higher than that estimated in the general population. Metabolic syndrome appears to be associated with an increased risk of major vascular events in our liver transplant population. Liver Transpl 13:1109–1114, 2007. © 2007 AASLD.Keywords
This publication has 21 references indexed in Scilit:
- Metabolic syndrome: A new view of some familiar transplant risksLiver Transplantation, 2006
- Cardiovascular risk factors after liver transplantationLiver Transplantation, 2005
- National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart StudyCirculation, 2004
- Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States AdultsCirculation, 2004
- C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring StudyCirculation, 2004
- The Metabolic Syndrome as Predictor of Type 2 DiabetesDiabetes Care, 2003
- The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged MenPublished by American Medical Association (AMA) ,2002
- The long-term survival and causes of death in patients who survive at least 1 year after liver transplantationSurgery, 2002
- Analysis of causes of death in liver transplant recipients who survived more than 3 yearsLiver Transplantation, 2001
- Orthotopic liver transplantation using low-dose tacrolimus and sirolimusLiver Transplantation, 2001